A 55-year-old woman with long-standing type 2 diabetes and prior myocardial infarction has an HbA1c of 7.6% on metformin and basal insulin. Her eGFR i...

Question

A 55-year-old woman with long-standing type 2 diabetes and prior myocardial infarction has an HbA1c of 7.6% on metformin and basal insulin. Her eGFR is 55 mL/min/1.73 m². According to Diabetes Canada pharmacologic guidance, which additional antihyperglycaemic therapy is preferred to reduce cardiovascular risk?

Accepted Answer

Add an SGLT2 inhibitor with proven cardiovascular benefit

Answer

Add a sulphonylurea

Answer

Add a DPP-4 inhibitor

Answer

Add basal-bolus prandial insulin

Answer

Switch metformin to a thiazolidinedione

ca-mccqe1 MCQ (SBA): Type 2 diabetes with cardiovascular disease